HALDOL DECANOATE

50 Mg/Ml Solution for Injection

Janssen-Cilag LtdPA0748/021/001

SPC: MARKETING AUTHORISATION HOLDER

19 May 2015 - 23 Jun 2017	23 Jun 2017 - Present
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG UK	Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG UK

« Back

Follow medicine

Print

Latest Changes to Medicine Info & SPC

23 Jun 2017
SPC: DATE OF REVISION OF THE TEXT
23 Jun 2017
SPC: MARKETING AUTHORISATION NUMBER
23 Jun 2017
SPC: MARKETING AUTHORISATION HOLDER
23 Jun 2017
SPC: Special precautions for disposal of a used medicinal product or waste materials derived from such medicinal product and other handling of the product
23 Jun 2017
SPC: Preclinical safety data
23 Jun 2017
SPC: Pharmacokinetic properties
23 Jun 2017
SPC: Pharmacodynamic properties
23 Jun 2017
SPC: Overdose
23 Jun 2017
SPC: Undesirable effects
23 Jun 2017
SPC: Effects on ability to drive and use machines
23 Jun 2017
SPC: Fertility, pregnancy and lactation
23 Jun 2017
SPC: Interaction with other medicinal products and other forms of interaction
23 Jun 2017
SPC: Special warnings and precautions for use
23 Jun 2017
SPC: Contraindications
23 Jun 2017
SPC: Posology and method of administration
23 Jun 2017
SPC: Therapeutic Indications
23 Jun 2017
SPC: PHARMACEUTICAL FORM
23 Jun 2017
SPC: QUALITATIVE AND QUANTITATIVE COMPOSITION
25 Aug 2015
ATC Code(s)

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.

HALDOL DECANOATE

SPC: MARKETING AUTHORISATION HOLDER

Latest Changes to Medicine Info & SPC

Important information regarding cookies and the HPRA